{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=HIB&page=2", "query": { "intervention": "HIB", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=HIB&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-02T20:07:15.688Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01129362", "title": "Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pertussis" ], "interventions": [ { "name": "Pentacel® (DTaP-IPV/Hib)", "type": "BIOLOGICAL" }, { "name": "Other Pertussis Vaccines", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": "59 Months", "sex": "ALL", "summary": "Up to 59 Months" }, "enrollment_count": 1195, "start_date": "2010-02-08", "completion_date": "2014-12-30", "has_results": false, "last_update_posted_date": "2022-04-25", "last_synced_at": "2026-09-02T20:07:15.688Z", "location_count": 2, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01129362" }, { "nct_id": "NCT00802867", "title": "Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diphtheria", "Tetanus", "Pertussis", "Polio", "Haemophilus Infection" ], "interventions": [ { "name": "Diphtheria and Tetanus Toxoids and Acellular Pertussis (DAPTACEL®)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "4 Years", "maximum_age": "6 Years", "sex": "ALL", "summary": "4 Years to 6 Years" }, "enrollment_count": 989, "start_date": "2004-02", "completion_date": "2005-09", "has_results": true, "last_update_posted_date": "2016-04-14", "last_synced_at": "2026-09-02T20:07:15.688Z", "location_count": 19, "location_summary": "Jonesboro, Arkansas • Little Rock, Arkansas • Oakland, California + 16 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Oakland", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00802867" }, { "nct_id": "NCT00255047", "title": "Safety and Immune Response of Different Pediatric Combination Vaccines.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diphtheria", "Polio", "Pertussis" ], "interventions": [ { "name": "DAPTACEL®. (DTaP), IPOL®., and ActHIB®.", "type": "BIOLOGICAL" }, { "name": "Pentacel®: DTaP-IPV/Hib combined", "type": "BIOLOGICAL" }, { "name": "DTaP-IPV and ActHIB®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "89 Days", "sex": "ALL", "summary": "42 Days to 89 Days" }, "enrollment_count": 2167, "start_date": "2005-11", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2014-02-14", "last_synced_at": "2026-09-02T20:07:15.688Z", "location_count": 36, "location_summary": "Tuscaloosa, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 29 more", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00255047" }, { "nct_id": "NCT04978818", "title": "Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Haemophilus Influenzae Type B Infection" ], "interventions": [ { "name": "Vaxelis", "type": "DRUG" }, { "name": "PedvaxHIB", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins Bloomberg School of Public Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 333, "start_date": "2022-01-27", "completion_date": "2023-10-26", "has_results": true, "last_update_posted_date": "2024-06-24", "last_synced_at": "2026-09-02T20:07:15.688Z", "location_count": 5, "location_summary": "Anchorage, Alaska • Chinle, Arizona • Fort Defiance, Arizona + 2 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Chinle", "state": "Arizona" }, { "city": "Fort Defiance", "state": "Arizona" }, { "city": "Gallup", "state": "New Mexico" }, { "city": "Shiprock", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT04978818" }, { "nct_id": "NCT00614614", "title": "Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Infections, Meningococcal" ], "interventions": [ { "name": "GSK Biologicals' Meningococcal vaccine GSK134612 (Nimenrix)", "type": "BIOLOGICAL" }, { "name": "GSK Biologicals' Hib-meningococcal vaccine GSK 792014 (Menhibrix)", "type": "BIOLOGICAL" }, { "name": "Infanrix®", "type": "BIOLOGICAL" }, { "name": "ActHIB®", "type": "BIOLOGICAL" }, { "name": "Pediarix®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 1558, "start_date": "2008-02-13", "completion_date": "2009-09-17", "has_results": true, "last_update_posted_date": "2018-09-21", "last_synced_at": "2026-09-02T20:07:15.688Z", "location_count": 56, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Benton, Arkansas + 50 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Benton", "state": "Arkansas" }, { "city": "Fayetteville", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00614614" }, { "nct_id": "NCT06038617", "title": "Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Fever After Vaccination", "Fever", "Seizures Fever" ], "interventions": [ { "name": "mRNA COVID-19 Vaccine", "type": "BIOLOGICAL" }, { "name": "Routine Childhood Vaccinations", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "4 Years", "sex": "ALL", "summary": "6 Months to 4 Years" }, "enrollment_count": 347, "start_date": "2023-10-30", "completion_date": "2025-07-25", "has_results": true, "last_update_posted_date": "2026-05-13", "last_synced_at": "2026-09-02T20:07:15.688Z", "location_count": 5, "location_summary": "Oakland, California • Atlanta, Georgia • New York, New York + 2 more", "locations": [ { "city": "Oakland", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "New York", "state": "New York" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06038617" }, { "nct_id": "NCT05095844", "title": "National Vaccine Adverse Event Reporting Survey and Etiology", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "COVID-19", "Vaccine Adverse Reaction", "Vaccine Reaction", "Vaccine or Biological Substance, Unspecified Causing Adverse Effects in Therapeutic Use", "Corona Virus Infection", "Blood Clot", "Thrombocytopenia", "Neuritis", "Vasculitis", "Influenza", "Guillain-Barré", "GWAS", "Genetic Sequencing" ], "interventions": [ { "name": "vaccinated", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Neuroganics LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "5 Years to 99 Years" }, "enrollment_count": 100000, "start_date": "2022-03-15", "completion_date": "2024-04-01", "has_results": false, "last_update_posted_date": "2022-03-18", "last_synced_at": "2026-09-02T20:07:15.688Z", "location_count": 1, "location_summary": "Northglenn, Colorado", "locations": [ { "city": "Northglenn", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05095844" }, { "nct_id": "NCT01659996", "title": "Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Meningitis", "Meningococcal Infection", "Diphtheria", "Tetanus", "Pertussis", "Haemophilus Influenzae Serotype b (Hib)" ], "interventions": [ { "name": "Meningococcal polysaccharide diphtheria toxoid conjugate", "type": "BIOLOGICAL" }, { "name": "Meningococcal polysaccharide diphtheria toxoid conjugate + Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed", "type": "BIOLOGICAL" }, { "name": "Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "9 Months", "maximum_age": "18 Months", "sex": "ALL", "summary": "9 Months to 18 Months" }, "enrollment_count": 1394, "start_date": "2012-07", "completion_date": "2015-09", "has_results": true, "last_update_posted_date": "2015-12-15", "last_synced_at": "2026-09-02T20:07:15.688Z", "location_count": 56, "location_summary": "Birmingham, Alabama • Pinson, Alabama • Tucson, Arizona + 50 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Pinson", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01659996" }, { "nct_id": "NCT01000974", "title": "Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Haemophilus Influenzae Type b" ], "interventions": [ { "name": "GSK Biologicals' Haemophilus influenzae type b vaccine (GSK 208108)", "type": "BIOLOGICAL" }, { "name": "ActHIB™", "type": "BIOLOGICAL" }, { "name": "Pentacel™", "type": "BIOLOGICAL" }, { "name": "Pediarix™", "type": "BIOLOGICAL" }, { "name": "Prevnar 13™", "type": "BIOLOGICAL" }, { "name": "Rotarix™", "type": "BIOLOGICAL" }, { "name": "Engerix™-B", "type": "BIOLOGICAL" }, { "name": "Infanrix™", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 4003, "start_date": "2010-06-18", "completion_date": "2013-07-17", "has_results": true, "last_update_posted_date": "2018-07-12", "last_synced_at": "2026-09-02T20:07:15.688Z", "location_count": 63, "location_summary": "Dothan, Alabama • Benton, Arkansas • Fayetteville, Arkansas + 59 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Benton", "state": "Arkansas" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01000974" }, { "nct_id": "NCT01000311", "title": "A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningococcal Disease" ], "interventions": [ { "name": "MenACWY-CRM", "type": "BIOLOGICAL" }, { "name": "DTaP-IPV/Hib", "type": "BIOLOGICAL" }, { "name": "HBV", "type": "BIOLOGICAL" }, { "name": "PCV", "type": "BIOLOGICAL" }, { "name": "MMR", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novartis Vaccines", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Days", "maximum_age": "89 Days", "sex": "ALL", "summary": "55 Days to 89 Days" }, "enrollment_count": 529, "start_date": "2009-11", "completion_date": "2011-11", "has_results": true, "last_update_posted_date": "2014-04-21", "last_synced_at": "2026-09-02T20:07:15.688Z", "location_count": 42, "location_summary": "Birmingham, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 33 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Canoga Park", "state": "California" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01000311" } ] }